Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study Academic Article Article uri icon

Overview

MeSH Major

  • Alpha Particles
  • Bone Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • Radium

abstract

  • Medivation, the Prostate Cancer Foundation, National Cancer Institute, the Howard Hughes Medical Institute, Doris Duke Charitable Foundation, and Department of Defense Prostate Cancer Clinical Trials Consortium.

publication date

  • April 14, 2010

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(10)60172-9

PubMed ID

  • 20398925

Additional Document Info

start page

  • 1437

end page

  • 46

volume

  • 375

number

  • 9724